A5041530289- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Lung Cancer Diagnosis and Treatment
- Advances in Oncology and Radiotherapy
- Brain Metastases and Treatment
- Bone health and treatments
- Lung Cancer Research Studies
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Health Systems, Economic Evaluations, Quality of Life
- Cancer-related cognitive impairment studies
- Obesity, Physical Activity, Diet
- Colorectal and Anal Carcinomas
- Lung Cancer Treatments and Mutations
- Bladder and Urothelial Cancer Treatments
- Blood transfusion and management
- Endometrial and Cervical Cancer Treatments
- Colorectal Cancer Surgical Treatments
- Cancer Diagnosis and Treatment
- Radiation Therapy and Dosimetry
- Erythropoietin and Anemia Treatment
- Glioma Diagnosis and Treatment
- Smoking Behavior and Cessation
- Health and Lifestyle Studies
Hospital Universitario Rey Juan Carlos
2015-2025
Hospital Del Mar
2021
Hospital del Mar Research Institute
2021
Municipal Institute for Medical Research
2021
Universidad de Zaragoza
2005-2020
Instituto de Salud Carlos III
2020
Instituto de Investigación Sanitaria Aragón
2020
Hospital Central de la Defensa Gómez Ulla
2005-2013
Hospital Clínico Universitario Lozano Blesa
2005
Radiation dose received by the neural stem cells of hippocampus during whole-brain radiotherapy has been associated with neurocognitive decline. The key concern using hippocampal avoidance-prophylactic cranial irradiation (HA-PCI) in patients small-cell lung cancer (SCLC) is incidence brain metastasis within avoidance zone.This phase III trial enrolled 150 SCLC (71.3% limited disease) to standard prophylactic (PCI; 25 Gy 10 fractions) or HA-PCI. primary objective was delayed free recall...
Owing to the limited validity of clinical data on treatment prostate cancer (PCa) and bone metastases, biochemical markers are a promising tool for predicting survival, disease progression skeletal-related events (SREs) in these patients. The aim this study was evaluate predictive capacity turnover mortality risk, SREs patients with PCa metastases undergoing zoledronic acid (ZA). This an observational, prospective multicenter which ninety-eight were included. Patients treated ZA (4 mg every...
Objective: To compare heart abnormalities in a group of malnourished children with control and to describe their predictive variables.Methods: Thirty malnutrition were matched thirty healthy children. Anthropometry, plasma levels albumin electrolytes determined. Among others, corrected QT interval (QTc) dispersion (QTd: difference between the maximum minimum QT) measured 12-lead electrocardiogram; left ventricular mass (LVm) index (LVmi) by echocardiography. Regression analyses performed...
Levels of bone turnover markers (BTM) might be correlated with outcome in terms skeletal-related events (SRE), disease progression, and death patients bladder cancer (BC) renal cell carcinoma (RCC) metastases (BM). We try to evaluate this possible correlation who receive treatment zoledronic acid (ZOL). This observational, prospective, multicenter study analysed BTM clinical these patients. Serum levels alkaline phosphatase (BALP), procollagen type I amino-terminal propeptide (PINP),...
Abstract Aim To investigate whether increased brain natriuretic propeptide (NT-proBNP) levels at 48 to 72 h of life are associated with the development bronchopulmonary dysplasia (BPD) or death in premature neonates. Methods A retrospective study was performed neonates born before 32 weeks’ gestation birth weight below 1500 grams, whom NT-proBNP determination and echocardiography were life. Associations between combined outcome BPD analyzed using multivariate logistic regression analysis....
Abstract Purpose To assess the validity, reliability, and responsiveness of Spanish version Expanded Prostate cancer Index Composite (EPIC) with 26 items. Methods Multicentric longitudinal study patients diagnosed localized or locally advanced prostate (any T, any N, M0) treated active surveillance, surgery, external radiotherapy, brachytherapy. The EPIC-50 was administered initially to cohort ( n = 324 patients), until it replaced in November 2019 by EPIC-26 543), both groups before...